Foundation Model of the immune system. Building a foundation model of the immune system to power blueprints for therapeutics. Owns the world's largest proprietary immune platform with HD discovery that finds rare cells others miss, feeding a database that trains AI to turn biological complexity into de-risked drug development assets.
52%
Revenue Growth (YoY)
$8M
Previous Round
The world's largest proprietary immune platform featuring HD discovery technology that identifies rare cells others miss. The platform feeds a comprehensive database that trains AI models to transform biological complexity into de-risked drug development assets. Powers therapeutic blueprints for pharmaceutical companies and research institutions, with capabilities that grow stronger with every new client engagement.
Click to read more